Fascaplysin inhibit ovarian cancer cell proliferation and metastasis through inhibiting CDK4
Author:
Funder
National Natural Science Foundation of China
China Medical University
Publisher
Elsevier BV
Subject
Genetics,General Medicine
Reference38 articles.
1. The history and future of targeting cyclin-dependent kinases in cancer therapy;Asghar;Nat. Rev. Drug Discov.,2015
2. CDK4: a key player in the cell cycle, development, and cancer;Baker;Genes Cancer,2012
3. Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy;Barretina;Nat. Genet.,2010
4. The CDK inhibitors in cancer research and therapy;Cicenas;J. Cancer Res. Clin. Oncol.,2011
5. Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies;Delbridge;Nat. Rev. Cancer,2016
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of Novel Candidate Targets for Fascaplysin through In Silico and In Vivo Analyses of Shared Targets among Structurally Similar Compounds;Pharmacognosy Magazine;2024-09-04
2. A systematic review on understanding the mechanistic pathways and clinical aspects of natural CDK inhibitors on cancer progression.: Unlocking cellular and biochemical mechanisms;Chemico-Biological Interactions;2024-04
3. Marine-Derived Bisindoles for Potent Selective Cancer Drug Discovery and Development;Molecules;2024-02-21
4. A New Mild Method for Synthesis of Marine Alkaloid Fascaplysin and Its Therapeutically Promising Derivatives;Marine Drugs;2023-07-25
5. Scutellaria baicalensis Georgi and Their Natural Flavonoid Compounds in the Treatment of Ovarian Cancer: A Review;Molecules;2023-06-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3